Register Login

ATHIRA PHARMA, INC. (LONA)

SymbolLONA
NameATHIRA PHARMA, INC.
SectorHEALTH CARE
RegionNorth America
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
Address18706 NORTH CREEK PARKWAY,SUITE 104, BOTHELL, Washington, 98011, United States
Telephone+1 425 620-8501
Fax—
Email—
Websitehttps://www.athira.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001620463
Description

Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimers disease and Parkinsons disease.

Additional info from NASDAQ:
LeonaBio, headquartered in the Seattle, Washington area, is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS), with the goal of improving patients lives. Our lead drug candidates, lasofoxifene and ATH-1105, are novel, small molecule therapies with the potential to address devastating diseases where current treatment options are limited or ineffective. With a strong commitment to scientific excellence and patient-centered innovation, we are dedicated to developing meaningful new therapies for those who need them most.

Additional info from NASDAQ:
Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimers disease and Parkinsons disease.

2026-08-14 20:07

(10% Negative) ATHIRA PHARMA, INC. (LONA) Reports Q3 2026 Financial Results

Read more
2026-08-14 20:05

LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update

Read more
2026-06-24 22:35

Callori Fred 🟢 acquired 2.3K shares (1 derivative) of LeonaBio, Inc. (LONA) at $8.35 Transaction Date: Jun 23, 2026 | Filing ID: 000006

Read more
2026-06-24 22:34

Holles Natalie C. 🟢 acquired 2.3K shares (1 derivative) of LeonaBio, Inc. (LONA) at $8.35 Transaction Date: Jun 23, 2026 | Filing ID: 000010

Read more
2026-06-24 22:33

Silverman Peter B. 🟢 acquired 2.3K shares (1 derivative) of LeonaBio, Inc. (LONA) at $8.35 Transaction Date: Jun 23, 2026 | Filing ID: 000004

Read more
2026-06-24 22:33

Panzara Michael A. 🟢 acquired 28.0K shares (1 derivative) of LeonaBio, Inc. (LONA) at $8.35 Transaction Date: Jun 23, 2026 | Filing ID: 000003

Read more
2026-06-24 22:31

Romano Kelly A 🟢 acquired 28.0K shares (1 derivative) of LeonaBio, Inc. (LONA) at $8.35 Transaction Date: Jun 23, 2026 | Filing ID: 000005

Read more
2026-06-24 22:31

EDELMAN JOSEPH 🟢 acquired 28.0K shares (1 derivative) of LeonaBio, Inc. (LONA) at $8.35 Transaction Date: Jun 23, 2026 | Filing ID: 000003

Read more
2026-06-24 22:30

JOHNSON JAMES A 🟢 acquired 28.0K shares (1 derivative) of LeonaBio, Inc. (LONA) at $8.35 Transaction Date: Jun 23, 2026 | Filing ID: 000003

Read more
2026-06-24 22:29

Kosacz Barbara 🟢 acquired 28.0K shares (1 derivative) of LeonaBio, Inc. (LONA) at $8.35 Transaction Date: Jun 23, 2026 | Filing ID: 000004

Read more